Filing Details
- Accession Number:
- 0001062993-24-013012
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-25 16:19:07
- Reporting Period:
- 2024-06-21
- Accepted Time:
- 2024-06-25 16:19:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1603454 | Celcuity Inc. | CELC | Services-Medical Laboratories (8071) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1688319 | E Richard Buller | 16305 36Th Avenue North Suite 100 Minneapolis MN 55446 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-06-21 | 350 | $15.68 | 7,381 | No | 4 | S | Indirect | By Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Trust |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,079 | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | $5.50 | 2029-12-03 | 4,555 | 4,555 | Indirect | |
| Common Stock | Stock Option (right to buy) | $5.10 | 2030-05-14 | 12,654 | 12,654 | Indirect | |
| Common Stock | Stock Option (right to buy) | $5.50 | 2031-05-12 | 2,310 | 2,310 | Indirect | |
| Common Stock | Stock Option (right to buy) | $5.50 | 2032-05-17 | 19,558 | 19,558 | Indirect | |
| Common Stock | Stock Option (right to buy) | $9.58 | 2033-05-15 | 8,733 | 8,733 | Indirect | |
| Common Stock | Stock Option (right to buy) | $14.83 | 2034-06-04 | 6,522 | 6,522 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2029-12-03 | 4,555 | 4,555 | Indirect |
| 2030-05-14 | 12,654 | 12,654 | Indirect |
| 2031-05-12 | 2,310 | 2,310 | Indirect |
| 2032-05-17 | 19,558 | 19,558 | Indirect |
| 2033-05-15 | 8,733 | 8,733 | Indirect |
| 2034-06-04 | 6,522 | 6,522 | Direct |
Footnotes
- Excludes 5,773 shares previously owned directly which were transferred to a living trust, of which the Reporting Person and his spouse are the trustees and beneficiaries. The Reporting Person continues to beneficially own these securities held by the trust.
- Represents 1,079 shares of restricted stock for which risks of forfeiture lapse on April 30, 2025, or if earlier, the date of the Company's 2025 Annual Meeting of Stockholders.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2023.
- The Reporting Person and his spouse are the trustees and beneficiaries. The Reporting Person continues to beneficially own these securities held by the trust.
- 100% vested.
- This Option will vest and become exercisable on April 30, 2025, or if earlier, the date of the Company's 2025 Annual Meeting of Stockholders.
Billionaire Hedge Funds
